Boehringer Ingelheim appoints new chairman

Boehringer Ingelheim has announced that Professor Andreas Barner will be retiring as chairman of the board of managing directors, to be succeeded by Hubertus von Baumbach.

Professor Barner will step down from the role on June 30th 2016 and will move to the company's shareholders' committee. He joined Boehringer Ingelheim in 1992 and has been credited with helping to realign the company's research, development and medical activities.

His work has enabled Boehringer Ingelheim to introduce a number of innovative therapies, further consolidating and expanding the company's independence as a family-owned business.

Mr von Baumbach has been a member of the board of managing directors since 2009 and is head of its corporate board division for finance.

Christian Boehringer, chairman of the shareholders' committee, said: "Hubertus von Baumbach knows the corporation and its various divisions and his time on the board of managing directors has prepared him well for the company's future challenges."

Boehringer Ingelheim also announced that Dr Michel Pairet will become a member of the board of managing directors with responsibility for the corporate business division for research and nonclinical development.